Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
about
Recent advancements in multimodality treatment of gliomasAtypical teratoid/rhabdoid tumors: challenges and search for solutionsMultimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature.Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with MedulloblastomaIntegrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsHigh-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous systemAtypical teratoid rhabdoid tumor in the cavernous sinus of a toddler presenting with oculomotor nerve palsy.Childhood brain tumors: epidemiology, current management and future directions.Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010.Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformationRare primary central nervous system tumors.Adult-onset sellar and suprasellar atypical teratoid rhabdoid tumor treated with a multimodal approach: a case reportCase report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor.Treatment outcomes and late toxicities in patients with embryonal central nervous system tumorsTumors of the central nervous system in children and adolescents.Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous systemAtypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused reviewCisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cellsDisrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target.High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival.Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells.Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition.Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children.Novel cell lines established from pediatric brain tumors.Atypical teratoid rhabdoid tumor: current therapy and future directions.Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumorsTargeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells.The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicitySequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system.Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation.Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007.Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid TumorAtypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.
P2860
Q27001724-3D9AA143-6B0E-43AE-A413-7794A09C1C84Q28066905-96AE2EF7-2083-4B69-9A2A-7917192B802FQ31028255-1D8152C6-5617-43C2-B6F1-B9D7EB7E91FBQ33645991-EB3876E1-DFDF-496F-9D46-D511E0AF8AE8Q33807896-D7E6A251-FD96-4D4B-AF66-4CC0443C4B78Q33882326-0379AC36-DC1B-4EA9-A2D3-5F214902016AQ33892097-61DEB0BE-3B6A-4D8B-B8E1-5D45578CA784Q33917487-081ED324-13E6-4531-AF90-979FAE43F093Q33970971-3ACC2173-7EC0-4CF5-B076-B2A9969E6542Q34132814-F98C7485-5442-437A-AAA1-25BF5DC22339Q34193770-6A727E09-CE50-4035-A5F3-53C86499D44EQ34213023-BE6C9152-D54E-4786-8DAE-C87D40D2F0ECQ34259193-A5D61E6E-3DC5-4FA2-9199-7EDCDF19D512Q34509409-9C241BAC-9066-4B4E-A1AB-EA30228D4B6AQ34627709-56AF948F-40F6-441B-B455-004552E679A1Q34667517-49CFDECA-4394-4A2C-8AE5-2E8084865390Q35069870-62781B77-6D0A-4B4E-82EE-41F8C5843503Q35083170-C1C8DB17-F96A-458D-B84A-EBE4B846320CQ35119982-912F608D-C48E-4D56-823F-EB5C40869211Q35176432-B139F4C6-1D63-4869-B552-72707E527C6DQ35550199-858EC0F1-8E36-4C3B-A023-26E29C636EF4Q35570270-1A7898C8-B079-4022-9749-EB38255B3027Q35696415-F31DF308-BACD-418A-B4E1-1C0EAF59CDB6Q35730809-5C80C53B-AC0E-4D39-B089-6AC935E56763Q35753503-6BE2A18A-DBC0-4D44-9FD1-8C62B9968007Q35754390-45736626-D472-452E-AAC7-B0576A85CF1CQ35789013-661D1242-EB3B-4F2C-AEA1-3B1F450B7ED5Q36047046-2CD0A18B-D2DC-4407-9E59-E83D21843551Q36227670-10904246-7831-42D5-8A5F-CFD49F91ECAFQ36250723-8FD98D60-0F8C-4371-BC84-AB08728FF345Q36377784-6131B77D-CD67-4925-8050-61AC34F6DFC5Q36416243-871CA5B8-68FB-4375-97C8-5C0F6922DA0BQ36489422-77D918D0-AAE0-4872-AD0F-AC60CD81C769Q36511670-42BF20E5-29F8-4E1E-A1B2-550844131D39Q36536422-D33F903A-0DCA-4680-B2B0-484796C21695Q36544065-832FA98E-0835-4452-AAF8-2A2F413E471CQ36893203-0320656F-A875-438C-AD66-F42C74623384Q36945821-82DA7C12-37EE-45F7-9293-8F846BE4D25FQ37367443-782A4F92-6919-4474-9932-898A001B49F0Q37595251-A14B97F8-F87E-4799-BB56-B0C9468196D5
P2860
Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Intensive Multimodality Treatm ...... ypical Teratoid Rhabdoid Tumor
@ast
Intensive Multimodality Treatm ...... ypical Teratoid Rhabdoid Tumor
@en
type
label
Intensive Multimodality Treatm ...... ypical Teratoid Rhabdoid Tumor
@ast
Intensive Multimodality Treatm ...... ypical Teratoid Rhabdoid Tumor
@en
prefLabel
Intensive Multimodality Treatm ...... ypical Teratoid Rhabdoid Tumor
@ast
Intensive Multimodality Treatm ...... ypical Teratoid Rhabdoid Tumor
@en
P2093
P2860
P3181
P356
P1476
Intensive multimodality treatm ...... ypical teratoid rhabdoid tumor
@en
P2093
Anna Janss
Anne Bendel
Christopher D Turner
Claire Mazewski
Daniel C Bowers
Jaclyn A Biegel
Joshua Rubin
Karen J Marcus
Kenneth J Cohen
Liliana Goumnerova
P2860
P304
P3181
P356
10.1200/JCO.2008.18.7724
P407
P577
2008-12-08T00:00:00Z